P. Martin Paslick - 12 Apr 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
14 Apr 2023, 17:51:12 UTC
Prior SEC filing
12 Apr 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Natalie Harrison Cline, Attorney-in-Fact

Key filing fact

P. Martin Paslick filed Form 4 for HCA Healthcare, Inc. (HCA) on 14 Apr 2023.

Key facts

  • This page summarizes P. Martin Paslick's Form 4 filing for HCA Healthcare, Inc. (HCA).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 14 Apr 2023, 17:51.

Change

  • Previous filing in this sequence was filed on 12 Apr 2023.
  • Current net transaction value: -$1,214,303.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Options Exercise

Transaction value
$519,626
Shares
+6,340
Change %
+26%
Price
$81.96
Shares after
30,983
Date
12 Apr 2023
Ownership
Direct
Footnotes
F1
HCA transaction

Common Stock

Tax liability

Transaction value
$995,004
Shares
-3,653
Change %
-12%
Price
$272.38
Shares after
27,330
Date
12 Apr 2023
Ownership
Direct
Footnotes
F1
HCA transaction

Common Stock

Sale

Transaction value
$738,925
Shares
-2,687
Change %
-9.8%
Price
$275.00
Shares after
24,643
Date
14 Apr 2023
Ownership
Direct
Footnotes
F1
HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,000
Date
12 Apr 2023
Ownership
by 2021 Trust
HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
60,000
Date
12 Apr 2023
Ownership
By PMP 2020 Trust
HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
63,999
Date
12 Apr 2023
Ownership
by RJP 2020 Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HCA transaction Derivative

Stock Appreciation Right

Options Exercise

Transaction value
$0
Shares
-6,340
Change %
-100%
Price
$0.000000*
Shares after
0
Date
12 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,340
Exercise price
$81.96
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The exercise of stock appreciation rights and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 10, 2022.

Footnote F2

The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .